<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04665440</url>
  </required_header>
  <id_info>
    <org_study_id>2020-00101</org_study_id>
    <nct_id>NCT04665440</nct_id>
  </id_info>
  <brief_title>Response of Preterm Infants to Multisensory Stimuli</brief_title>
  <acronym>OXYVOICE</acronym>
  <official_title>Variation of Salivary Oxytocin and Cortisol Levels in Premature Neonates and Their Mothers in Response to Multi-sensory Stimuli</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to measure the variation of oxytocin and cortisol levels in the&#xD;
      saliva of premature neonates and their mother after sensorial stimuli.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to measure the variation of oxytocin and cortisol levels in the&#xD;
      saliva of neonates with gestational age ranging from 32 to 34 completed weeks and in the&#xD;
      saliva of their mothers. The measurements are taken before and after sensorial stimuli&#xD;
      including mother voice exposure +/- tactile distraction for 10 minutes. The two interventions&#xD;
      are performed between day 5 and day 12 after birth and 24 to 48 hours apart. Each child is&#xD;
      randomised in a group depending on order of the two interventions.&#xD;
&#xD;
      Investigators hypothesize that an increase in the oxytocin/cortisol ratio will be occurred in&#xD;
      neonates after hearing their mothers and that simultaneous tactile stimulation will mitigate&#xD;
      that effect.&#xD;
&#xD;
      Concomitantly, the neonate's vital signs and his facial expressions are recorded during&#xD;
      interventions. The mothers anxiety level is assessed PSS-NICU questionnaire given before the&#xD;
      first and after the second intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>prospective randomised crossover study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxytocin/cortisol ratio</measure>
    <time_frame>at baseline and 10 minutes after intervention</time_frame>
    <description>Change in salivary oxytocin/cortisol ratio in response to the intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vital signs</measure>
    <time_frame>at baseline, during and 10 minutes after intervention</time_frame>
    <description>Change in heart rate and respiratory rate in response to the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Facial expression analysis</measure>
    <time_frame>at baseline, during and 10 minutes after intervention</time_frame>
    <description>Response of neonate to intervention analysed by standardized neonatal facial coding system score, measured on video recording before, during and after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mother anxiety and mother infant bond</measure>
    <time_frame>at baseline and 10 minutes after intervention</time_frame>
    <description>Level of the mothers anxiety and her bond to the infant analyzed using NICU-PSS questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Mother-Infant Interaction</condition>
  <arm_group>
    <arm_group_label>Voice only then distraction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>First intervention: mother's voice without tactile stimuli Second intervention: mother's voice with tactile stimuli</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Distraction then voice only</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>First intervention: mother's voice with tactile stimuli Second intervention: mother's voice without tactile stimuli</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Voice alone</intervention_name>
    <description>mother's voice without tactile stimuli</description>
    <arm_group_label>Distraction then voice only</arm_group_label>
    <arm_group_label>Voice only then distraction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Voice + tactile stimuli</intervention_name>
    <description>mother's voice with tactile stimuli</description>
    <arm_group_label>Distraction then voice only</arm_group_label>
    <arm_group_label>Voice only then distraction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Newborn gestational age 32 0/7 weeks to 34 6/7 weeks&#xD;
&#xD;
          -  Born at university hospital Geneva&#xD;
&#xD;
          -  French speaking parents&#xD;
&#xD;
          -  Out of incubator&#xD;
&#xD;
          -  Signed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Newborn with one of the above conditions:&#xD;
&#xD;
          -  Congenital malformation&#xD;
&#xD;
          -  intraventricular hemorrhage grade III or IV&#xD;
&#xD;
          -  white matter abnormality&#xD;
&#xD;
          -  anti-epileptic or sedative drugs&#xD;
&#xD;
          -  altered consciousness level&#xD;
&#xD;
          -  Infant requiring respiratory support&#xD;
&#xD;
          -  psychiatric disorders in the mother or antenatal use of psychoactive drugs&#xD;
&#xD;
          -  Bilateral absent otoacoustic emissions and/or auditory evoked potential&#xD;
&#xD;
          -  Parents refusal to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>32 Weeks</minimum_age>
    <maximum_age>35 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olivier Baud, Prof.</last_name>
    <phone>0033625951299</phone>
    <email>olivier.baud@hcuge.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jessica Hirschel, Dr.</last_name>
    <phone>0041763847907</phone>
    <email>jessica.hirschel@hcuge.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpitaux Universitaires Genève</name>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Baud, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Jessica Hirschel, Dr.</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Filippa M, Panza C, Ferrari F, Frassoldati R, Kuhn P, Balduzzi S, D'Amico R. Systematic review of maternal voice interventions demonstrates increased stability in preterm infants. Acta Paediatr. 2017 Aug;106(8):1220-1229. doi: 10.1111/apa.13832. Epub 2017 Apr 19. Review.</citation>
    <PMID>28378337</PMID>
  </reference>
  <reference>
    <citation>Weber A, Harrison TM, Sinnott L, Shoben A, Steward D. Plasma and Urinary Oxytocin Trajectories in Extremely Premature Infants During NICU Hospitalization. Biol Res Nurs. 2017 Oct;19(5):549-558. doi: 10.1177/1099800417718266. Epub 2017 Jul 12.</citation>
    <PMID>28699358</PMID>
  </reference>
  <reference>
    <citation>Vittner D, McGrath J, Robinson J, Lawhon G, Cusson R, Eisenfeld L, Walsh S, Young E, Cong X. Increase in Oxytocin From Skin-to-Skin Contact Enhances Development of Parent-Infant Relationship. Biol Res Nurs. 2018 Jan;20(1):54-62. doi: 10.1177/1099800417735633. Epub 2017 Oct 11.</citation>
    <PMID>29017336</PMID>
  </reference>
  <reference>
    <citation>Zinni M, Colella M, Batista Novais AR, Baud O, Mairesse J. Modulating the Oxytocin System During the Perinatal Period: A New Strategy for Neuroprotection of the Immature Brain? Front Neurol. 2018 Apr 13;9:229. doi: 10.3389/fneur.2018.00229. eCollection 2018. Review.</citation>
    <PMID>29706926</PMID>
  </reference>
  <reference>
    <citation>Lejeune F, Brand LA, Palama A, Parra J, Marcus L, Barisnikov K, Debillon T, Gentaz E, Berne-Audéoud F. Preterm infant showed better object handling skills in a neonatal intensive care unit during silence than with a recorded female voice. Acta Paediatr. 2019 Mar;108(3):460-467. doi: 10.1111/apa.14552. Epub 2018 Sep 21.</citation>
    <PMID>30144160</PMID>
  </reference>
  <reference>
    <citation>Kuhn P, Sizun J, Casper C; GREEN study group from the French Neonatal Society. Recommendations on the environment for hospitalised newborn infants from the French neonatal society: rationale, methods and first recommendation on neonatal intensive care unit design. Acta Paediatr. 2018 Nov;107(11):1860-1866. doi: 10.1111/apa.14501. Epub 2018 Aug 13. Review.</citation>
    <PMID>30025190</PMID>
  </reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 3, 2020</study_first_submitted>
  <study_first_submitted_qc>December 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2020</study_first_posted>
  <last_update_submitted>December 10, 2020</last_update_submitted>
  <last_update_submitted_qc>December 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Prof. Olivier BAUD, MD-PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>neonates</keyword>
  <keyword>oxytocin</keyword>
  <keyword>late preterm</keyword>
  <keyword>stress</keyword>
  <keyword>family-centered intervention</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

